Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cipla
Citi
Accenture
Mallinckrodt
Harvard Business School
Moodys
Boehringer Ingelheim
Daiichi Sankyo

Generated: April 23, 2018

DrugPatentWatch Database Preview

MELAMISA Drug Profile

« Back to Dashboard

When do Melamisa patents expire, and what generic alternatives are available?

Melamisa is a drug marketed by Novast Labs Ltd and is included in one NDA.

The generic ingredient in MELAMISA is drospirenone; ethinyl estradiol. There are ten drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol profile page.
Summary for MELAMISA
Drug patent expirations by year for MELAMISA

US Patents and Regulatory Information for MELAMISA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs Ltd MELAMISA drospirenone; ethinyl estradiol TABLET;ORAL 202016-001 Jan 26, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Daiichi Sankyo
Dow
Covington
Moodys
Boehringer Ingelheim
Johnson and Johnson
Accenture
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.